Adicet Bio Statistics
Total Valuation
Adicet Bio has a market cap or net worth of $121.36 million. The enterprise value is $18.46 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Adicet Bio has 161.70 million shares outstanding. The number of shares has increased by 42.22% in one year.
| Current Share Class | 153.25M |
| Shares Outstanding | 161.70M |
| Shares Change (YoY) | +42.22% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 24.10% |
| Float | 134.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.48, with a Debt / Equity ratio of 0.12.
| Current Ratio | 7.48 |
| Quick Ratio | 7.32 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -63,086.50 |
Financial Efficiency
Return on equity (ROE) is -64.39% and return on invested capital (ROIC) is -39.14%.
| Return on Equity (ROE) | -64.39% |
| Return on Assets (ROA) | -36.52% |
| Return on Invested Capital (ROIC) | -39.14% |
| Return on Capital Employed (ROCE) | -86.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$780,500 |
| Employee Count | 152 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.52% in the last 52 weeks. The beta is 1.63, so Adicet Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.63 |
| 52-Week Price Change | -47.52% |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 0.77 |
| Relative Strength Index (RSI) | 37.63 |
| Average Volume (20 Days) | 3,309,244 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -126.17M |
| Pretax Income | -118.64M |
| Net Income | -118.64M |
| EBITDA | -119.62M |
| EBIT | -126.17M |
| Earnings Per Share (EPS) | -$1.30 |
Full Income Statement Balance Sheet
The company has $124.96 million in cash and $15.36 million in debt, giving a net cash position of $109.61 million or $0.68 per share.
| Cash & Cash Equivalents | 124.96M |
| Total Debt | 15.36M |
| Net Cash | 109.61M |
| Net Cash Per Share | $0.68 |
| Equity (Book Value) | 133.37M |
| Book Value Per Share | 1.45 |
| Working Capital | 110.66M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$98.14 million and capital expenditures -$2.12 million, giving a free cash flow of -$100.25 million.
| Operating Cash Flow | -98.14M |
| Capital Expenditures | -2.12M |
| Free Cash Flow | -100.25M |
| FCF Per Share | -$0.62 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Adicet Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -42.22% |
| Shareholder Yield | -42.22% |
| Earnings Yield | -92.64% |
| FCF Yield | -78.28% |
Dividend Details Analyst Forecast
The average price target for Adicet Bio is $6.00, which is 699.47% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 699.47% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -58.19% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |